Division of Geriatrics, Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China. 2

Size: px
Start display at page:

Download "Division of Geriatrics, Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China. 2"

Transcription

1 Journals of Gerontology: MEDICAL SCIENCES The Author Published by Oxford University Press on behalf of The Gerontological Society of America. Cite journal as: J Gerontol A Biol Sci Med Sci 2014 March;69(3): All rights reserved. For permissions, please journals.permissions@oup.com. doi: /gerona/glt098 Advance Access publication August 2, 2013 Outcomes in Older Adults With Stage 5 Chronic Kidney Disease: Comparison of Peritoneal Dialysis and Conservative Management Chun Keung Shum, 1,2 Kui Fu Tam, 1,2 Wai Leung Chak, 3 Tuen Ching Chan, 4 Ying Fai Mak, 1 and Ka Foon Chau 3 1 Division of Geriatrics, Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China. 2 Medical Unit, Hong Kong Buddhist Hospital, Hong Kong, China. 3 Division of Nephrology, Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China. 4 Division of Geriatrics, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China. Address correspondence to Chun Keung Shum, MBBS, Division of Geriatrics, Department of Medicine, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong, China. shum_ck@yahoo.com.hk Background. Data on the outcomes of older adults receiving peritoneal dialysis (PD), especially those who are dependent and have multiple comorbidities, are scarce. Methods. In a retrospective cohort study, we compared older adults ( 65 years) with stage 5 chronic kidney disease receiving PD (PD group) with those receiving conservative management (conservative group). Baseline characteristics (demographics and clinical, functional, socioeconomic, and laboratory parameters) were collected, and study outcomes (patient survival, emergency hospitalization, institutionalization, and palliative and end-of-life care) were compared between groups. Results. We included 199 eligible participants aged years (mean ± standard deviation 73.8 ± 5.4 years; 157 in the PD group and 42 in the conservative group). The PD group had a longer survival (median [interquartile range]: 3.75 [ ] vs 2.35 [ ] years, p <.001), lower emergency hospitalization rates (1.63 [ ] vs 3.51 [ ] per person-year, p <.01) and hospital days (16.17 [ ] vs [ ] days per person-year, p =.03), and no increased risk of institutionalization compared with the conservative group. Age (hazard ratio [HR] for 1-year increase 1.06, 95% confidence interval [CI] ), modified Charlson s Comorbidity Index (HR 1.36, 95% CI ), impairment in basic activities of daily living (HR 2.11, 95% CI ), and emergency dialysis (HR 1.67, 95% CI ) were independent predictors of mortality in the PD group. Conclusion. PD is a viable treatment option in older adults with stage 5 chronic kidney disease. Age alone should not preclude dialysis. Comprehensive geriatric assessment can prognosticate and facilitate shared decision making to commence dialysis in older adults. Key Words: Chronic kidney disease Elderly Dialysis Conservative management Outcome. Received December 23, 2012; Accepted May 26, 2013 Decision Editor: Stephen Kritchevsky, PhD Age is no longer seen as a contraindication to dialysis. Owing to aging population and improved management of comorbid diseases, there are increasing numbers of older adults with stage 5 chronic kidney disease (CKD) (1,2). Technological advances in renal replacement therapy (RRT), increased acceptance, and more liberal access to dialysis have resulted in rapid expansion in geriatric dialysis population (3 5). The fastest growth has been seen particularly in the age group older than 75 years, many of whom are dependent, frail, and have multiple comorbidities (6,7). In the United States, individuals older than 75 years showed a 67% increase in the incidence of stage 5 CKD compared with 24% for those between 5 and 74 years during , and the highest rates of dialysis initiation were found in those between 75 and 84 years (2). In Hong Kong, there were 3321 peritoneal dialysis (PD) patients in Among them, 1465 (44.1%) were aged 65 years or above (8,9). The benefits of dialysis in older adults, especially those who are very old, are dependent, and have multiple comorbidities, are questionable compared with those of conservative management (4). Hong Kong has a PD-first policy and follows the international guidelines on the standard of dialysis care (9). People with stage 5 CKD will receive PD as the first modality of long-term RRT unless contraindicated. In 2007, 80% of patients with stage 5 CKD (median age 62.3 years) were on PD in Hong Kong (10,11). Previous studies were limited and mainly focused on 308

2 PERITONEAL DIALYSIS IN OLDER ADULTS 309 survival outcomes in older adults receiving hemodialysis. There are little data regarding the efficacy of PD in older adults. We performed a study to compare the survival and nonsurvival outcomes of PD versus conservative management in Chinese older adults. Methods Study Design and Recruitment A retrospective cohort study was conducted in Queen Elizabeth Hospital in Hong Kong serving a cluster of 0.5 million population (Kowloon Central Cluster). In this cluster, all patients before starting long-term RRT would have dialysis assessment. All Chinese older adults ( 65 years) with stage 5 CKD (defined as estimated glomerular filtration rate [egfr] < 15 ml/min/1.73 m 2 using the Modification of Diet in Renal Disease equation) (12) who received dialysis assessment were retrospectively identified over a 7-year period (from July 1, 2003 to June 30, 2010). The date of study entry was the date of dialysis assessment, and the date of study end was on December 31, Participants were followed up till death or for a minimum of 1.5 years if still alive on the date of study end. They were categorized into conservative group (defined as those who received no dialysis or conservative management after dialysis assessment ) and PD group (defined as those who received PD as the first modality of longterm RRT or had made a decision to commence on PD and had begun preparation for the temporary dialysis, PD catheter insertion but had died before dialysis initiation). It was a complex shared decision making between patients/ families and doctors to commence dialysis or conservative management, and the final decision was largely voluntary to the patients. Participants in the conservative group would receive the same level of medical care as those in the PD group except no PD. Regular follow-ups were provided in medical clinics and/or nurse-led clinics to optimize medical management of renal disease (eg, anemia treatment by erythropoietin, fluid and electrolyte balance, management of uremic symptoms), and telephone hotline was provided for symptom control. Data Collection Data were collected by retrospective review of computerized records and case notes. Baseline characteristics of participants were recorded during dialysis assessment : (a) demographics age and gender; (b) clinical data etiology of CKD, modified Charlson s Comorbidity Index (mcci) (13), late referral (defined as dialysis assessment required shortly within 1 month after seen by nephrologists), and emergency dialysis (defined as temporary dialysis required during emergency admission before starting long-term RRT); (c) functional aspects basic activities of daily living (BADL; independent or impaired) and mobility (independent walker, assisted walker, chairbound/bedridden); (d) socioeconomic factors marital status, educational level, living status, receiving Comprehensive Social Security Allowance (CSSA), any helper for PD; and (e) laboratory parameters egfr, sodium, potassium, calcium, phosphate, bicarbonate, albumin, and hemoglobin levels. Other data on participants reasons for no dialysis in the conservative group and need for assistance for PD in the PD group (self-pd [PD performed by participants] and assisted PD [PD performed by their caregivers]), were collected. Outcomes Primary outcome was survival (defined as patient survival from the date of entry into stage 5 CKD to death or study end). The date of entry into stage 5 CKD was the date of first recorded value of egfr less than 15 ml/ min/1.73 m 2 and participants need to fulfill two criteria: (a) at least one value of egfr in the range of ml/ min/1.73 m 2 and (b) all subsequent recorded values of egfr less than 15 ml/min/1.73 m 2. Secondary outcomes included emergency hospitalization rate (number of emergency hospitalizations per year of follow-up), emergency hospital days (number of hospital days due to emergency hospitalizations per year of follow-up), institutionalization (new admission to a nursing home), and palliative and endof-life care (renal palliative care, bothersome interventions during end-of-life period [defined as one of the following invasive interventions within 1 month before death: operative or endoscopic intervention, intubation or mechanical ventilation, cardiopulmonary resuscitation, tube feeding for artificial nutrition]). The study was approved by the Research Ethics Committee at the Kowloon Central Cluster, Hospital Authority, Hong Kong. Statistical Analyses Groups were compared using chi-square test or Fisher exact test for categorical variables and using t test or Mann Whitney U test for continuous variables as appropriate. Kaplan Meier analyses were used to compare survival and institutionalization outcomes with group differences analyzed by log-rank test. Cox proportional regression analysis was used to determine the predictors of mortality. Linear regression was used to determine the predictors of emergency hospitalization after log transformation. Exploratory analyses using each of the variables (namely, demographics, clinical data, functional aspects, socioeconomic factors, laboratory parameters, and treatment modality) were used to assess the independent impact of predictors. Results were expressed as percentage (%) or number (n) for categorical variables, and means ± standard deviation (SD) or median (interquartile range) for continuous variables. In Cox proportional hazards model, hazard ratio (HR) and 95% confidence interval (95% CI) were estimated for

3 310 SHUM ET AL. each independent predictor. In linear regression model, standardized coefficient beta (β) was estimated for each independent predictor after log transformation. All variables had less than 5% missing data. Participants with missing data from dialysis assessment were excluded for the analysis of that variable. Statistical significance was set at p <.05. Statistical analyses were performed using SPSS, Version 19. Results A total of 199 older adults with stage 5 CKD aged years (mean ± SD: 73.8 ± 5.4 years) were included in this study: 42 (21.1%) in the conservative group and 157 (78.9%) in the PD group (Table 1). Participants had a median follow-up of 1.96 years (interquartile range years). In the PD group, 102 (71.8%) required assisted PD. Table 1. Baseline Characteristics Between Conservative and PD Groups at the Time of Dialysis Assessment Baseline Characteristics Conservative Group (n = 42)* PD Group (n = 157)* p Demographics Age (y) 75.3 ± ± Male (%) Etiology of CKD Diabetic nephropathy (%) Hypertensive nephrosclerosis (%) Glomerulonephritis (%) Polycystic kidney (%) Obstructive uropathy (%) Others/unknown (%) Comorbidity mcci 4.6 ± ± Diabetes mellitus (%) Coronary artery disease (%) Congestive heart failure (%) Stroke (%) Peripheral vascular disease (%) Chronic pulmonary disease (%) Liver disease (%) Cancer (%) Dementia (%) Clinical data Late referral (%) Functional Aspects BADL Independent BADL (%) Impaired BADL (%) Mobility Independent walker (%) Assisted walker (%) Chairbound/bedridden (%) Socioeconomic factors Single/divorced/separated (%) Illiterate (%) Living alone/in nursing home (%) Living in public housing (%) Receiving CSSA (%) No helper for PD (%) <.001 Laboratory parameters egfr (ml/min/1.73m 2 ) 6.8 ± ± Sodium (mmol/l) ± ± Potassium (mmol/l) 4.5 ± ± Calcium (mmol/l) 2.2 ± ± Phosphate (mmol/l) 1.9 ± ± Bicarbonate (mmol/l) 20.9 ± ± Albumin (g/l) 36.9 ± ± Hemoglobin (g/dl) 8.7 ± ± Notes: BADL = basic activities of daily living; CKD = chronic kidney disease; CSSA = Comprehensive Social Security Allowance; egfr = estimated glomerular filtration rate; mcci = modified Charlson s Comorbidity Index; PD = peritoneal dialysis. *Results expressed as % or mean ± standard deviation whenever appropriate.

4 PERITONEAL DIALYSIS IN OLDER ADULTS 311 Baseline Characteristics The conservative group was older (75.3 ± 5.7 vs 73.4 ± 5.3 years, p =.04), was more likely to have stroke (28.6% vs 14.0%, p =.03) and receive CSSA (24.4% vs 9.7%, p =.01), and had no helper for PD (58.8% vs 17.6%, p <.001) compared with the PD group. There was no significant difference in other characteristics at baseline (Table 1). Participants Reasons for No Dialysis In the conservative group, reasons for no dialysis were documented in 40 participants, and 35% (n = 14) had more than one reason. The most common reason was inability to perform PD but no helper available or refused institutionalization (40.0%, n = 16), followed by patient s choice (37.5%, n = 15), afraid of treatment and complication burden (22.5%, n = 9), advanced age (20.0%, n = 8), and comorbidities (17.5%, n = 7). Survival By the end of the study, 92.9% (n = 39) died in the conservative group, and 61.1% (n = 96) died in the PD group. The PD group had a longer median survival than the conservative group (median [interquartile range]: 3.75 [ ] vs 2.35 [ ] years, p <.001). Kaplan Meier curves showed survival advantage in the PD group (p <.001; Figure 1). In Cox proportional hazards model, age, mcci, BADL impairment, and emergency dialysis were independent predictors of mortality in the PD group (Table 2). After adjustment for age, mcci, and BADL impairment, survival advantage persisted in the PD group (p <.001, HR 0.46, 95% CI ) compared with the conservative group. In subgroup analyses, the survival advantage was preserved in those receiving PD with low comorbidity or independent BADL but was lost in those with high comorbidity or BADL impairment (Figures 2 and 3). Hospitalization The PD group had significantly lower emergency hospitalization rates (1.63 [ ] vs 3.51 [ ] per person-year, p <.01) and hospital days (16.17 [ ] vs [ ] days per person-year, p =.03) than the conservative group. In multivariate linear regression, independent predictors of emergency hospitalization rate and hospital days (after log transformation) included PD (β = 0.18, p =.01; β = 0.14, p =.04), age (β = 0.21, p <.01; β = 0.17, p =.02), mcci (β = 0.22, p <.01; β = 0.17, p =.01), and BADL impairment (β = 0.20, p <.01; β = 0.22, p <.01). The differences in emergency hospitalization between groups remained significant even after adjustment for age, mcci, and BADL impairment. Figure 1. Kaplan Meier survival curves for participants in conservative and peritoneal dialysis groups. CKD = chronic kidney disease; PD = peritoneal dialysis.

5 312 SHUM ET AL. Table 2. Cox Proportional Hazards Model for Independent Predictors of Mortality in the PD Group Independent Predictors of Mortality in the PD Group HR (95% CI) p Age (y) 1.06 ( ).01 mcci 1.36 ( ) <.001 BADL impairment 2.11 ( ) <.01 Emergency dialysis 1.67 ( ).02 Notes: BADL = basic activities of daily living; CI = confidence interval; HR = hazard ratio; mcci = modified Charlson s Comorbidity Index; PD = peritoneal dialysis. Institutionalization The PD group had no significant increased risk of institutionalization compared with the conservative group (p =.20). Palliative and End-of-Life Care The conservative group was more likely to receive renal palliative care (15.4% vs 0%, p <.001) and less likely to receive bothersome interventions during end-of-life period (47.2% vs 85.9%, p <.001) than the PD group. Figure 2. Comparison of Kaplan Meier survival curves for participants in conservative and peritoneal dialysis groups with low and high comorbidity. mcci = modified Charlson s Comorbidity Index; PD = peritoneal dialysis. Figure 3. Comparison of Kaplan Meier survival curves for participants in conservative and peritoneal dialysis groups with independent and impaired BADL. BADL = basic activities of daily living; PD = peritoneal dialysis.

6 PERITONEAL DIALYSIS IN OLDER ADULTS 313 Discussion PD can be a viable treatment option in older adults with stage 5 CKD. In this study, PD could improve survival and reduce the risk of emergency hospitalization without an increased risk of institutionalization compared with conservative management. To our knowledge, this is the first study to compare the survival and nonsurvival outcomes between PD and conservative management in Chinese older adults with stage 5 CKD. Age alone should not preclude dialysis. In this study, survival benefit was present in older adults receiving PD compared with conservative management. Previous studies mainly focused on comparing survival outcomes between groups of adults predominantly receiving hemodialysis versus conservative management. The studies by Chandna and coworkers, Carson and coworkers, and Murtagh and coworkers showed that people on dialysis lived significantly longer than people managed conservatively, but conservatively managed people were older or more likely to have high comorbidity (14 17). The study by Joly and coworkers (18) also revealed a large survival benefit in octogenarians proposed dialysis, but the group not proposed dialysis was more likely to have diabetes, have a lower functional score, be referred late, and be socially isolated. However, the study by Smith and coworkers (19) showed no significant survival difference between conservatively managed people and people recommended for conservative management but opting for and treated by dialysis. As a whole, survival benefit of dialysis is probably present in selected groups of older adults. In this study, older adults receiving PD had significantly lower emergency hospitalization. A previous study has shown that people on dialysis (predominantly hemodialysis) had higher hospitalization rates and similar hospitalfree survivals compared with conservatively managed people (16). The discrepancy may be explained by homebased PD having advantages over in-center hemodialysis in older adults. PD can avoid continuous and exhaustive trips to and from the hospital, have less intrusion into lifestyle, and better preserve residual renal function with less hemodynamic stress during treatment, and there is no need for vascular access (10,20,21). In this study, the PD group had no increased risk of institutionalization. Institutionalization was found to be an indirect manifestation of functional decline and increased caregiver burden (22,23). We proposed that proper selection of older adults receiving dialysis should not result in unnecessary institutionalization and sacrifice of function. Geriatric population is a heterogeneous population with a variety of functions and comorbidities (10). Chronological age is not equivalent to physical and mental age (11). In this study, mcci and BADL impairment were independent predictors of survival and emergency hospitalization. Past studies also showed that the survival benefit of dialysis was lost in older adults (>75 years) with high comorbidity or ischemic heart disease compared with conservative management (15,17), and a prediction model for 6-month mortality was validated in older adults receiving dialysis including comorbidities and functional status (total dependency for transfers) (24 26). In another study, the use of surprise question ( Would I be surprised if this patient died in the next year? ) was effective in identifying hemodialysis patients who had a higher risk for early mortality. Not surprised group was significantly older, had a higher comorbidity score, and had a lower performance status (27,28). Hence, comprehensive geriatric assessment including comorbidity and functional status should be considered in addition to age in older adults to commence dialysis (24,29 31). In older adults with stage 5 CKD, especially in those who are very old with multiple comorbidities and functional impairment, conservative management is a reasonable alternative. The survival advantage of dialysis may probably be lost in these people, and they may suffer from repeated hospitalizations. Moreover, the conservative group was more likely to receive renal palliative care and less likely to receive bothersome interventions during end-of-life period. Previous studies also found that in conservatively managed people, age older than 75 years and female gender were independent predictors of improved survival (15), and they were more likely to die at home or in a hospice (4,16). Conservative management, also known as maximum conservative management, is not simply defined by no dialysis (32). It shifts the focus from efforts to prolong life to those that focus on symptom control, quality of life, and care support by a multidisciplinary team approach. It embodies active disease management (eg, anemia treatment by erythropoietin, fluid and electrolyte balance, management of uremic symptoms), end-of-life care, and ongoing psychosocial and spiritual support to patients and family/ caregivers (4,5,7). Nevertheless, prognostication and decision making to commence dialysis remain difficult and should be individualized (1,20,32 34). Collaboration between geriatric and nephrology teams can be essential to provide multidisciplinary and multifactorial assessment and intervention in older adults with stage 5 CKD (24,35). There were a number of limitations in the study. First, the study was retrospective in nature, but it is unethical to randomize people to dialysis or conservative management. Second, the sample size was small. However, the benefit can be clearly shown by this sample size. Third, selection bias might be present in this study. A group of older adults with good functioning and low comorbidity might be selected for dialysis assessment (Table 1), and there was no data on the percentage of older adults with stage 5 CKD who were not referred for dialysis assessment. Last, symptom burden, quality of life, and functional outcomes were not assessed. Future large prospective cohort studies investigating symptom burden, quality of life, and functional outcomes in

7 314 SHUM ET AL. addition to survival of older adults receiving dialysis versus conservative management are warranted (15,17). Conclusion PD is a viable treatment option in older adults with stage 5 CKD. Age alone is not a contraindication to dialysis. Comprehensive geriatric assessment can be important to prognosticate and facilitate shared decision making to commence dialysis in older adults. In those who are very old with multiple comorbidities and functional impairment, conservative management is a reasonable alternative. References 1. Brunori G, Viola BF, Maiorca P, Cancarini G. How to manage elderly patients with chronic renal failure: conservative management versus dialysis. Blood Purif. 2008;26: Misra M. Dialysis in the elderly. Blood Purif. 2008;26: Kooman JP, Cornelis T, van der Sande FM, Leunissen KM. Renal replacement therapy in geriatric end-stage renal disease patients: a clinical approach. Blood Purif. 2012;33: Burns A, Carson R. Maximum conservative management: a worthwhile treatment for elderly patients with renal failure who choose not to undergo dialysis. J Palliat Med. 2007;10: Burns A, Davenport A. Maximum conservative management for patients with chronic kidney disease stage 5. Hemodial Int. 2010; 14(suppl 1):S32 S Selvarajah V, Isles C. End-stage renal disease in the very elderly. J R Coll Physicians Edinb. 2007;37: Dasgupta I, Rayner HC. In good conscience safely withholding dialysis in the elderly. Semin Dial. 2009;22: Ho YW, Leung CB, Choy BY, et al. Renal registry and peritoneal dialysis management: the Hong Kong perspective. Perit Dial Int. 2008;28(suppl 3):S12 S Li PK, Law MC, Chow KM, et al. Good patient and technique survival in elderly patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2007;27(suppl 2):S196 S Dimkovic N, Oreopoulos D. Management of elderly patients with end-stage kidney disease. Semin Nephrol. 2009;29: Brown EA, Johansson L. Epidemiology and management of end-stage renal disease in the elderly. Nat Rev Nephrol. 2011;7: Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17: Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis. 2003;42: O Connor NR, Kumar P. Conservative management of end-stage renal disease without dialysis: a systematic review. J Palliat Med. 2012;15: Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant. 2011;26: Carson RC, Juszczak M, Davenport A, Burns A. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol. 2009;4: Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant. 2007;22: Joly D, Anglicheau D, Alberti C, et al. Octogenarians reaching endstage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol. 2003;14: Smith C, Da Silva-Gane M, Chandna S, Warwicker P, Greenwood R, Farrington K. Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract. 2003;95:c40 c Buemi M, Lacquaniti A, Bolignano D, et al. Dialysis and the elderly: an underestimated problem. Kidney Blood Press Res. 2008;31: Li PK, Chow KM. Peritoneal dialysis patient selection: characteristics for success. Adv Chronic Kidney Dis. 2009;16: Gaugler JE, Duval S, Anderson KA, Kane RL. Predicting nursing home admission in the U.S: a meta-analysis. BMC Geriatr. 2007;7: Tsuji I, Whalen S, Finucane TE. Predictors of nursing home placement in community-based long-term care. J Am Geriatr Soc. 1995;43: Swidler MA. Geriatric renal palliative care. J Gerontol A Biol Sci Med Sci. 2012;67: Couchoud C, Labeeuw M, Moranne O, et al.; French Renal Epidemiology and Information Network (REIN) registry. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant. 2009;24: Hudson M, Weisbord S, Arnold RM. Prognostication in patients receiving dialysis #191. J Palliat Med. 2007;10: Cohen LM, Ruthazer R, Moss AH, Germain MJ. Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol. 2010;5: Moss AH, Ganjoo J, Sharma S, et al. Utility of the surprise question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol. 2008;3: Bowling CB, Muntner P. Epidemiology of chronic kidney disease among older adults: a focus on the oldest old. J Gerontol A Biol Sci Med Sci. 2012;67: Bowling CB, Sawyer P, Campbell RC, Ahmed A, Allman RM. Impact of chronic kidney disease on activities of daily living in communitydwelling older adults. J Gerontol A Biol Sci Med Sci. 2011;66: Gopinath B, Harris DC, Burlutsky G, Mitchell P. Use of community support services and activity limitations among older adults with chronic kidney disease. J Gerontol A Biol Sci Med Sci. 2013;68: Fassett RG, Robertson IK, Mace R, Youl L, Challenor S, Bull R. Palliative care in end-stage kidney disease. Nephrology (Carlton). 2011;16: Jassal SV, Kelman EE, Watson D. Non-dialysis care: an important component of care for elderly individuals with advanced stages of chronic kidney disease. Nephron Clin Pract. 2011;119(suppl 1):c5 c Swidler M. Geriatric renal palliative care is coming of age. Int Urol Nephrol. 2010;42: Moranne O, Couchoud C, Vigneau C; PSPA Study Investigators. Characteristics and treatment course of patients older than 75 years, reaching end-stage renal failure in France. The PSPA study. J Gerontol A Biol Sci Med Sci. 2012;67:

Abstract. Introduction. Volume 54 Number 4 Oct. - Dec., Philippine Journal of Internal Medicine. Original Paper

Abstract. Introduction. Volume 54 Number 4 Oct. - Dec., Philippine Journal of Internal Medicine. Original Paper Philippine Journal of Internal Medicine Original Paper A Comparison Between Dialysis Versus Conservative Management as Modes of Treatment in the Management of Elderly Patients with End Stage Renal Disease:

More information

Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy

Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy Nephrol Dial Transplant (2011) 26: 1608 1614 doi: 10.1093/ndt/gfq630 Advance Access publication 22 November 2010 Survival of elderly patients with stage 5 CKD: comparison of conservative management and

More information

Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5

Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 Nephrol Dial Transplant (2007) 22: 1955 1962 doi:10.1093/ndt/gfm153 Advance Access publication 4 April 2007 Original Article Dialysis or not? A comparative survival study of patients over 75 years with

More information

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,

More information

Assisted Peritoneal Dialysis

Assisted Peritoneal Dialysis Assisted Peritoneal Dialysis BC Kidney Days Vancouver, BC Matthew Oliver MD MHS Sunnybrook Health Sciences Centre University of Toronto Oct 18, 2012 Declaration 2 Co-inventor of the Dialysis Measurement

More information

Outcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote

Outcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote Outcomes of dialysis in the elderly DNT March 2011 Dr Céline Foote Increasing number of elderly patients on renal replacement therapy 500 500 Patients per million 400 300 200 100 400 300 200 100 TOTAL

More information

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have

More information

Meeting the Guidelines for End-of-Life Care

Meeting the Guidelines for End-of-Life Care Advances in Peritoneal Dialysis, Vol. 22, 2006 Gillian Brunier, David M.J. Naimark, Michelle A. Hladunewich Meeting the Guidelines for End-of-Life Care The number of patients initiating dialysis in most

More information

WebEx Quick Reference

WebEx Quick Reference Session 2 Drs. Alvin Moss & David Weissman WebEx Quick Reference Welcome to today s session! Please use Chat to All Raise your hand Participants for questions For technology issues only, please Chat to

More information

ANZSN Renal Supportive Care Guidelines 2013

ANZSN Renal Supportive Care Guidelines 2013 bs_bs_banner Nephrology 18 (2013) 401 454 Reviews ANZSN Renal Supportive Care Guidelines 2013 THE OFTEN DIFFICULT DECISION OF WHICH PATIENTS WILL BENEFIT FROM DIALYSIS Mark A Brown 1 and Susan M Crail

More information

Renal replacement therapy for patients with diabetes mellitus in Hong Kong

Renal replacement therapy for patients with diabetes mellitus in Hong Kong Hong Kong J Journal Nephrol of 2001;3(2):89-96. Nephrology 2001;3(1):89-96. Y CHOY, et al R E N L REGISTRY Renal replacement therapy for patients with diabetes mellitus in Hong Kong o-ying CHOY 1, Yiu-Wing

More information

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 53 years old female, -worked as computer scientist, -lived with her husband and 2 children, -in excellent financial situation. Diagnosed with

More information

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Palliative care for advanced renal disease: A summary of the evidence and future direction

Palliative care for advanced renal disease: A summary of the evidence and future direction 491796PMJ27910.1177/0269216313491796Palliative MedicineKane et al. 2013491796PMJ Special Article PALLIATIVE MEDICINE Palliative care for advanced renal disease: A summary of the evidence and future direction

More information

King s Research Portal

King s Research Portal King s Research Portal DOI: 10.2215/CJN.04840516 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Murtagh, F. E. M., Burns,

More information

FIRST RENAL REPLACEMENT

FIRST RENAL REPLACEMENT FIRST RENAL REPLACEMENT THERAPY SELECTION IN DIABETIC PATIENTS Dr Cécile Couchoud (REIN registry, France) Davide Bolignano (ERBP, Italy) European Renal Best Practice Prof. Wim Van Biesen Chairman of ERBP

More information

A CONCEPT NOTE FOR PALLIATIVE CARE IN INDIA: USING THE EXAMPLE OF CHRONIC KIDNEY DISEASE

A CONCEPT NOTE FOR PALLIATIVE CARE IN INDIA: USING THE EXAMPLE OF CHRONIC KIDNEY DISEASE A CONCEPT NOTE FOR PALLIATIVE CARE IN INDIA: USING THE EXAMPLE OF CHRONIC KIDNEY DISEASE Dr.Mukesh Shete Consultant Nephrologist Director, Apex Kidney Care DEFINITION AND CONCEPTUAL FRAMEWORK OF SUPPORTIVE

More information

Marginal Dialysis: Patient characteristics influencing outcomes

Marginal Dialysis: Patient characteristics influencing outcomes Marginal Dialysis: Patient characteristics influencing outcomes Dr Celine Foote Staff specialist, Concord Repatriation General Hospital Post-Doctoral Research Fellow, The George Institute for Global Health

More information

AJNT. Original Article

AJNT. Original Article . 2012 May;5(2):81-6 Original Article AJNT Reaching Target Hemoglobin Level and Having a Functioning Arteriovenous Fistula Significantly Improve One Year Survival in Twice Weekly Hemodialysis Sarra Elamin

More information

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis Advances in Peritoneal Dialysis, Vol. 24, 2008 Matthew J. Novak, 1 Heena Sheth, 2 Filitsa H. Bender, 1 Linda Fried, 1,3 Beth Piraino 1 Improvement in Pittsburgh Symptom Score Index After Initiation of

More information

Geriatric Nephrology. Murtener Tage

Geriatric Nephrology. Murtener Tage Geriatric Nephrology Murtener Tage 2014 Isabelle.Binet@kssg.ch www.nierenstiftung.ch Plan Geriatric nephrology The elderly with CKD The elderly on dialysis The elderly in transplantation Plan Geriatric

More information

Applying clinical guidelines treating and managing CKD

Applying clinical guidelines treating and managing CKD Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012

More information

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care SERVICE SPECIFICATION 6 Conservative Management & End of Life Care Table of Contents Page 1 Key Messages 2 2 Introduction & Background 2 3 Relevant Guidelines & Standards 2 4 Scope of Service 3 5 Interdependencies

More information

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,

More information

Acceptance onto dialysis guidelines: St George Hospital

Acceptance onto dialysis guidelines: St George Hospital Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines

More information

Appendix 1 (as submitted by the authors): Search strategy and rationale behind judgments of risk of bias using the Quality in Prognosis Studies tool

Appendix 1 (as submitted by the authors): Search strategy and rationale behind judgments of risk of bias using the Quality in Prognosis Studies tool Appendix 1 (as submitted by the authors): Search strategy and rationale behind judgments of risk of bias using the Quality in Prognosis Studies tool Part 1: Search strategy to retrieve citations for the

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1* Cea Soriano et al. Cardiovascular Diabetology (2015) 14:38 DOI 10.1186/s12933-015-0204-5 CARDIO VASCULAR DIABETOLOGY ORIGINAL INVESTIGATION Open Access Cardiovascular events and all-cause mortality in

More information

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart. Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not

More information

Management of End Stage Renal Disease-Bangladesh Perspective

Management of End Stage Renal Disease-Bangladesh Perspective Send Orders for Reprints to reprints@benthamscience.net 108 The Open Urology & Nephrology Journal, 2014, 7, 108-112 Management of End Stage Renal Disease-Bangladesh Perspective Harun Ur Rashid * Open Access

More information

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Division of Nephrology, Department of Medicine University

More information

CKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College

CKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College CKD FOR INTERNISTS Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College INTRODUCTION In 2002, the National Kidney Foundation s Kidney Disease Outcomes Quality Initiative(KDOQI)

More information

Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease

Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease Int Urol Nephrol (2015) 47:1739 1744 DOI 10.1007/s11255-015-1087-9 NEPHROLOGY - ORIGINAL ARTICLE Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease Magdalena Jankowska

More information

Evidence-based practice in nephrology : Meta-analysis

Evidence-based practice in nephrology : Meta-analysis Evidence-based practice in nephrology : Meta-analysis Paweena Susantitaphong, MD,Ph.D 1-3 1 Associate Professor, Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn

More information

Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease

Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease CJASN epress. Published on August 10, 2016 as doi: 10.2215/CJN.04840516 Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease Fliss E.M. Murtagh,* Aine Burns, Olivier Moranne, Rachael

More information

King s Research Portal

King s Research Portal King s Research Portal DOI: 10.2215/CJN.04840516 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Murtagh, F. E. M., Burns,

More information

Improved survival of type 2 diabetic patients on renal replacement therapy in Finland

Improved survival of type 2 diabetic patients on renal replacement therapy in Finland Nephrol Dial Transplant (2010) 25: 892 896 doi: 10.1093/ndt/gfp555 Advance Access publication 21 October 2009 Improved survival of type 2 diabetic patients on renal replacement therapy in Finland Marjo

More information

Preservation of Veins and Timing for Vascular Access

Preservation of Veins and Timing for Vascular Access Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access

More information

Prevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study

Prevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study International Journal of Advances in Medicine Sathyan S et al. Int J Adv Med. 2017 Feb;4(1):247-251 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170120

More information

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage

More information

A comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol

A comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol A comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol Leanne Brown Master of Nursing Science (Nurse Practitioner) 1 Glenn Gardner

More information

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA

More information

Survival of Patients Over 75 Years of Age on Peritoneal Dialysis Therapy

Survival of Patients Over 75 Years of Age on Peritoneal Dialysis Therapy Advances in Peritoneal Dialysis, Vol. 26, 2010 Hiromichi Suzuki, Tsutomu Inoue, Yusuke Watanabe, Tomohiro Kikuta, Takahiko Sato, Masahiro Tsuda Survival of Patients Over 75 Years of Age on Peritoneal Dialysis

More information

Dialysis versus Supportive Care

Dialysis versus Supportive Care Dialysis versus Supportive Care with a focus on the initial pathway in the elderly DNT Workshop. Glenelg, February 2017 Background: A better title would be dialysis v non-dialysis! For this discussion:

More information

Predictive Factors for Withdrawal from Peritoneal Dialysis: A Retrospective Cohort Study at Two Centers in Japan

Predictive Factors for Withdrawal from Peritoneal Dialysis: A Retrospective Cohort Study at Two Centers in Japan Advances in Peritoneal Dialysis, Vol. 33, 2017 Yasuhiro Taki, 1 Tsutomu Sakurada, 2 Kenichiro Koitabashi, 2 Naohiko Imai, 1 Yugo Shibagaki 2 Predictive Factors for Withdrawal from Peritoneal Dialysis:

More information

2015 Children's Mercy Hospitals and Clinics. All Rights Reserved.

2015 Children's Mercy Hospitals and Clinics. All Rights Reserved. Growth van Stralen KJ, et al., Kidney Int, 2014 Blood Pressure Management van Stralen KJ, et al., Kidney Int, 2014 Sodium Losses on PD Infants might need higher UF rate per BSA as compared to adults to

More information

Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology

Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology CKD Classification Stage Description GFR (ml/min/1.73.m2) 1 Kidney

More information

You can sleep while I dialyze

You can sleep while I dialyze You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep

More information

Age and treatment of kidney failure

Age and treatment of kidney failure REVIEW C URRENT OPINION Age and treatment of kidney failure Meghan J. Elliott a, Helen Tam-Tham b, Brenda R. Hemmelgarn a,b, for the Alberta Kidney Disease Network Purpose of review This review discusses

More information

Management of the Frail Older Patients: What Are the Outcomes

Management of the Frail Older Patients: What Are the Outcomes Management of the Frail Older Patients: What Are the Outcomes Professor Edwina Brown Imperial College Renal and Transplant Centre Hammersmith Hospital, London Increasing prevalence of old old on RRT RRT

More information

High prevalence of frailty in end-stage renal disease Drost, Diederik; Kalf, Annette; Vogtlander, Nils; van Munster, Barbara C.

High prevalence of frailty in end-stage renal disease Drost, Diederik; Kalf, Annette; Vogtlander, Nils; van Munster, Barbara C. University of Groningen High prevalence of frailty in end-stage renal disease Drost, Diederik; Kalf, Annette; Vogtlander, Nils; van Munster, Barbara C. Published in: International urology and nephrology

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease

More information

Survival after Dialysis Discontinuation and Hospice Enrollment for ESRD

Survival after Dialysis Discontinuation and Hospice Enrollment for ESRD CJASN epress. Published on November 7, 2013 as doi: 10.2215/CJN.04110413 Article Survival after Dialysis Discontinuation and Hospice Enrollment for ESRD Nina R. O Connor,* Meredith Dougherty,* Pamela S.

More information

A tale of two specialties

A tale of two specialties A tale of two specialties United Kingdom Annual Symposia on Renal-Palliative Care co-organised by both disciplines National Service Framework for Renal Services Part 2 (UK) - 2005 Concentrated on the

More information

Title:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients

Title:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients Author's response to reviews Title:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients Authors: Da Shang (sdshangda@163.com) Qionghong

More information

THE CONSERVATIVE CARE PATHWAY

THE CONSERVATIVE CARE PATHWAY THE CONSERVATIVE CARE PATHWAY Dr. Gaylene Hargrove Sept. 19, 2015 Island Health Renal Program End of Life Conference Learning Objectives Describe and discuss what defines conservative care. Identify key

More information

Chronic kidney disease and the aging population

Chronic kidney disease and the aging population J Nephrol (2014) 27:1 5 DOI 10.1007/s40620-014-0038-3 EDITORIAL Chronic kidney disease and the aging population Marcello Tonelli Miguel Riella Published online: 21 January 2014 Ó Italian Society of Nephrology

More information

Functional Status of Elderly Adults before and after Initiation of Dialysis

Functional Status of Elderly Adults before and after Initiation of Dialysis original article Functional Status of Elderly Adults before and after Initiation of Dialysis Manjula Kurella Tamura, M.D., M.P.H., Kenneth E. Covinsky, M.D., M.P.H., Glenn M. Chertow, M.D., M.P.H., Kristine

More information

Palliative and End of Life Care in End Stage Renal Disease

Palliative and End of Life Care in End Stage Renal Disease Palliative and End of Life Care in End Stage Renal Disease Palliative and End of Life Care Priority for Action Regional Consensus Workshop 30.06.2010 Neal Morgan Consultant Nephrologist SHSCT Outline Introduction

More information

UNIVERSITY OF CALGARY. diabetes mellitus. Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES

UNIVERSITY OF CALGARY. diabetes mellitus. Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES UNIVERSITY OF CALGARY Quality of care and outcomes for First Nations People and non-first Nations People with diabetes mellitus by Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL

More information

Evidence Table. Study Type: Randomized controlled trial. Study Aim: To compare frequent nocturnal hemodialysis and conventional in-center dialysis.

Evidence Table. Study Type: Randomized controlled trial. Study Aim: To compare frequent nocturnal hemodialysis and conventional in-center dialysis. Evidence Table Clinical Area: Reference: Frequent home dialysis Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass

More information

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist Screening and early recognition of CKD John Ngigi (FISN) Kidney specialist screening Why? Who? When? How? Primary diagnosis for patients who start dialysis Other 10% Glomerulonephritis 13% No. of dialysis

More information

Chronic renal disease in the elderly: are all pigs to be considered equal?

Chronic renal disease in the elderly: are all pigs to be considered equal? Chronic renal disease in the elderly: are all pigs to be considered equal? W. Van Biesen, Ghent University Hospital Elwood et al, cjasn, 2013 Elderly and CKD: a thematic synthesis Overview CKD in the

More information

Dialysis for everyone? Maurizio Gallieni

Dialysis for everyone? Maurizio Gallieni Dialysis for everyone? Maurizio Gallieni Nephrology and Dialysis Unit Ospedale S. Carlo Borromeo, ASST Santi Paolo e Carlo, University of Milano, Milano, Italy Introduction NDT 2004; 19: 1357-1360 www.

More information

Decision-making around commencing dialysis

Decision-making around commencing dialysis Decision-making around commencing dialysis A.M.Anutra Chittinandana, MD. Bhumibol Aduyadej Hospital Mr.H Mr. H was an 86-year-old man with diabetic and ischemic nephropathy, otherwise well. He was followed

More information

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD Karen Solcher, MSN, APRN, NP-C, CNN-NP Nephrology Nurse Practitioner Stormont-Vail Health DISCLAIMER Adult population Clinical practice

More information

( ) , (Donabedian, 1980) We would not choose any treatment with poor outcomes

( ) , (Donabedian, 1980) We would not choose any treatment with poor outcomes ..., 2013 Amgen. 1 ? ( ), (Donabedian, 1980) We would not choose any treatment with poor outcomes 1. :, 2. ( ): 3. :.,,, 4. :, [Biomarkers Definitions Working Group, 2001]., (William M. Bennet, Nefrol

More information

Faculty/Presenter Disclosure

Faculty/Presenter Disclosure CSI for CKD Unravelling the myths surrounding chronic kidney disease Practical Evidence for Informed Practice Oct 21 2016 Dr. Scott Klarenbach University of Alberta Slide 1: Option B (Presenter with NO

More information

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less Chapter 5: Joint Analyses with UK Transplant in England and Wales; Access to the Renal Transplant Waiting List, Time to Listing, Diabetic Access to Transplantation and the Influence of Social Deprivation

More information

The proportion of older people in the

The proportion of older people in the http://www.kidney-international.org 2014 International Society of Nephrology editorial Chronic kidney disease and the aging population Kidney International (2014) 85, 487 491. doi:10.1038/ki.2013.467 Marcello

More information

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report Chapter 12 End Stage Kidney Disease in Indigenous Peoples of and Aotearoa/ 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, the rates and practice patterns for end-stage

More information

Chronic Kidney Disease. Basics of CKD Terms Diagnosis Management

Chronic Kidney Disease. Basics of CKD Terms Diagnosis Management Chronic Kidney Disease Basics of CKD Terms Diagnosis Management Review the prevalence of chronic kidney disease (CKD) Review how CKD develops Review populations at risk for CKD Review CKD diagnosis Objectives

More information

Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases

Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases CLINICAL RESEARCH Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases Gerhard Lonnemann 1, Johannes Duttlinger 1, David Hohmann 2, Lennart

More information

The EQUAL study: a European study in chronic kidney disease stage 4 patients

The EQUAL study: a European study in chronic kidney disease stage 4 patients Nephrol Dial Transplant (2012) 27 (Supple 3): iii27 iii31 doi: 10.1093/ndt/gfs277 Advance Access publication 4 July 2012 Editorial Review The EQUAL study: a European study in chronic kidney disease stage

More information

Dialysis modality and 2-year outcomes in patients with ischemic cardiomyopathy and end-stage renal disease

Dialysis modality and 2-year outcomes in patients with ischemic cardiomyopathy and end-stage renal disease Dialysis modality and 2-year outcomes in patients with ischemic cardiomyopathy and end-stage renal disease Vinay Panday, Zi-Ping Tong, Perryn L. Ng, Evan J. Lee, Titus Lau, Boon-Wee Teo, Horng-Ruey Chua

More information

Contrast Induced Nephropathy

Contrast Induced Nephropathy Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)

More information

Chapter 25: Interactions of Dialysis Teams With Geriatricians

Chapter 25: Interactions of Dialysis Teams With Geriatricians Chapter 25: Interactions of Dialysis Teams With Geriatricians Nicole Stankus* and Kellie Campbell *Section of Nephrology, University of Chicago, Chicago, Illinois; and Section of Geriatrics, University

More information

Objectives At the end of the session, participants will be able to:

Objectives At the end of the session, participants will be able to: Living Well Without Dialysis Why Conservative Kidney Management? Dr. Sara Davison Professor of Medicine University of Alberta Director, Kidney Supportive Care Research Group Dr. Clare Gibson BSc, PhD Filmmaker,

More information

Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data

Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data DIALYSIS Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 7 to 14 Analysis From Henan Peritoneal Dialysis Registry data Xiaoxue Zhang, 1 Ying Chen, 1,2 Yamei Cai, 1 Xing Tian,

More information

PART ONE. Peritoneal Kinetics and Anatomy

PART ONE. Peritoneal Kinetics and Anatomy PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.

More information

KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription. January 25 28, 2018 Madrid, Spain

KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription. January 25 28, 2018 Madrid, Spain KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription January 25 28, 2018 Madrid, Spain Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization

More information

CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017

CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017 CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017 RENEGOTIATING LIFE WITH CHRONIC KIDNEY DISEASE CONSTANTINI

More information

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets

More information

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations NDT Advance Access published November 9, 2005 Nephrol Dial Transplant (2005) 1 of 8 doi:10.1093/ndt/gfi248 Original Article Effect of previously failed kidney transplantation on peritoneal dialysis outcomes

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and

More information

CHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition

CHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst 212 Annual Report 35th Edition PERITONEAL DIALYSIS ANZDATA Registry 212 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis

More information

Morbidity & Mortality from Chronic Kidney Disease

Morbidity & Mortality from Chronic Kidney Disease Morbidity & Mortality from Chronic Kidney Disease Dr. Lam Man-Fai ( 林萬斐醫生 ) Honorary Clinical Assistant Professor MBBS, MRCP, FHKCP, FHKAM, PDipID (HK), FRCP (Edin, Glasg) Hong Kong Renal Registry Report

More information

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 TREAT THE KIDNEY TO SAVE THE HEART Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 1 ESRD Prevalent Rates in 1996 per million population December

More information

Study of association of serum bicarbonate levels with mortality in chronic kidney disease

Study of association of serum bicarbonate levels with mortality in chronic kidney disease International Journal of Research in Medical Sciences Kumar S et al. Int J Res Med Sci. 2016 Nov;4(11):4852-4856 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20163779

More information

The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page

The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page 1589-1594 Using Serum Beta Trace Protein to Estimate Residual Kidney Function in Hemodialysis Patients Hesham M. El-Sayed, Hussein

More information

Malnutrition and inflammation in peritoneal dialysis patients

Malnutrition and inflammation in peritoneal dialysis patients Kidney International, Vol. 64, Supplement 87 (2003), pp. S87 S91 Malnutrition and inflammation in peritoneal dialysis patients PAUL A. FEIN, NEAL MITTMAN, RAJDEEP GADH, JYOTIPRAKAS CHATTOPADHYAY, DANIEL

More information

Although the overall incidence of ESRD in Western

Although the overall incidence of ESRD in Western Is Maximum Conservative Management an Equivalent Treatment Option to Dialysis for Elderly Patients with Significant Comorbid Disease? Rachel C. Carson,* Maciej Juszczak, Andrew Davenport, and Aine Burns

More information

CHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition

CHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition CHAPTER 6 Neil Boudville Hannah Dent Stephen McDonald Kylie Hurst Philip Clayton 213 Annual Report - 36th Edition ANZDATA Registry 213 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis was used to treat

More information

Research. Changes in survival among elderly patients initiating dialysis from 1990 to 1999

Research. Changes in survival among elderly patients initiating dialysis from 1990 to 1999 Changes in survival among elderly patients initiating dialysis from 1990 to 1999 Research Sarbjit Vanita Jassal MB BCh MD, Lilyanna Trpeski MPH MD, Naisu Zhu MD, Stanley Fenton MD, Brenda Hemmelgarn PhD

More information

The Renal Physicians Association Quality Improvement Registry

The Renal Physicians Association Quality Improvement Registry In collaboration with CECity The Renal Physicians Association Quality Improvement Registry This registry is approved by CMS as a Qualified Clinical Data Registry (QCDR) for Eligible Professionals and GPRO

More information

CHAPTER 6 PERITONEAL DIALYSIS

CHAPTER 6 PERITONEAL DIALYSIS CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani Hannah Dent Kylie Hurst Stephen McDonald PERITONEAL DIALYSIS ANZDATA Registry 11 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis was used to

More information

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012 Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012 Susan McKenna Renal Clinical Nurse Specialist Cavan General Hospital Renal patient population ACUTE RENAL FAILURE

More information

Nephrology. Renal Replacement in End-Stage Renal Disease Patients over 75 Years Old. ABC Fax

Nephrology. Renal Replacement in End-Stage Renal Disease Patients over 75 Years Old. ABC Fax American Journal of Nephrology Original Article: Basic Sciences Am J Nephrol 2003;23:7 77 DOI: 0.59/000068040 Received: July 23, 2002 Accepted: October 2, 2002 Renal Replacement in End-Stage Renal Disease

More information

The University of Mississippi School of Pharmacy

The University of Mississippi School of Pharmacy LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.

More information

Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case control study

Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case control study http://www.kidney-international.org & 2006 International Society of Nephrology Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case control study S Mujais

More information